Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2023
As of Dec 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q4 FY2021
As of Dec 31, 2021
ASSETS
Current assets:
Cash and cash equivalents
Prepaid expenses and other current assets
Total current assets
Non-current assets:
Property and equipment, net
Operating lease right of use assets
Deferred tax assets
Restricted cash
Other assets
Total non-current assets
TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Income taxes payable
Accrued expenses and other liabilities
Operating lease liabilities—current
Total current liabilities
Non-current liabilities:
Operating lease liabilities-non-current
Other long-term liability
Total non-current liabilities
Total liabilities
Shareholders' equity:
Ordinary shares, pound 0.001 par value; 41,082,948 and 40,932,727 shares authorized, issued and outstanding at December 31,2023 and 2022, respectively
Deferred shares, pound 92,451.851 par value, one share authorized, issued and outstanding at December 31, 2023 and 2022
Additional paid in capital
Accumulated other comprehensive income
Accumulated deficit
Total shareholders’ equity
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support